Alantra advised on the sale of NutraGenesis to Innophos

Mar 2017

Sell-side advisory

Alantra is pleased to announce the sale of NutraGenesis LLC, Icon Group LLC, and Tradeworks Group Inc. (collectively known as NutraGenesis), to Innophos Holdings, Inc. (NASDAQ: IPHS). The transaction was announced on November 6, 2017 with a total purchase price of $28m.

Based in Brattleboro, VT, NutraGenesis is a privately-held marketer of a broad portfolio of branded nutritional ingredients which target health issues such as stress reduction, weight control, joint health, brain health and metabolic wellness. NutraGenesis’ products are backed by strong scientific analysis (including human clinical studies) and sold to leading companies across the globe specializing in nutritional supplements and sports nutrition.

“The addition of NutraGenesis’ innovative, science-backed branded ingredients to our Food, Health and Nutrition portfolio more closely aligns Innophos with consumer mega-trends such as health and wellness, energized aging and clean labels,” said Kim Ann Mink, Ph.D., Chairman, President and Chief Executive Officer of Innophos Holdings, Inc. in a company statement. The NutraGenesis transaction is Innophos’ second human nutrition acquisition in recent months and supports the company’s stated growth strategy of becoming one of the world’s leading nutritional ingredient providers.

“The NutraGenesis transaction was completed in just over two months in terms of total time in the market,” said Joseph Downing, Managing Director with Alantra. “This is a testament to our client’s strong positioning in the nutrition market and established track record for developing innovative, science-backed ingredients,” he continued. “This is the third company we have sold to Innophos as they continue to expand their nutritional ingredient portfolio and market presence.”